Cleared Traditional

K220177 - Magnus Neuromodulation System (MNS) with SAINT Technology, Model Number 1001K (FDA 510(k) Clearance)

Sep 2022
Decision
223d
Days
Class 2
Risk

K220177 is an FDA 510(k) clearance for the Magnus Neuromodulation System (MNS) with SAINT Technology, Model Number 1001K. This device is classified as a Transcranial Magnetic Stimulator (Class II - Special Controls, product code OBP).

Submitted by Magnus Medical, Inc. (Burlingame, US). The FDA issued a Cleared decision on September 1, 2022, 223 days after receiving the submission on January 21, 2022.

This device falls under the Neurology FDA review panel. Regulated under 21 CFR 882.5805. A Transcranial Magnetic Stimulator Is A Device That Delivers Brief Duration, Rapidly Alternating, Or Pulsed, Magnetic Fields To Induce Electrical Currents That Are Directed At Spatially Discrete Regions Of The Cerebral Cortex For The Treatment Of Major Depressive Disorder..

Submission Details

510(k) Number K220177 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 21, 2022
Decision Date September 01, 2022
Days to Decision 223 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Summary PDF

Device Classification

Product Code OBP - Transcranial Magnetic Stimulator
Device Class Class II - Special Controls
CFR Regulation 21 CFR 882.5805
Definition A Transcranial Magnetic Stimulator Is A Device That Delivers Brief Duration, Rapidly Alternating, Or Pulsed, Magnetic Fields To Induce Electrical Currents That Are Directed At Spatially Discrete Regions Of The Cerebral Cortex For The Treatment Of Major Depressive Disorder.